Palbociclib slows tumour growth in early breast cancer
Adding the CDK4/6 inhibitor palbociclib to hormone therapy can slow or stop tumour growth in women with early breast cancer, a study in the Journal of Clinical Oncology has shown.
Source: Clinical Pharmacist - Category: Drugs & Pharmacology Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Drugs & Pharmacology | Hormonal Therapy | Hormones | Study | Women